Palforzia (peanut allergen powder-dnfp–Aimmune Therapeutics), which was FDA-approved in 2020, has been giving people with peanut allergies protection from severe reactions.

Clarissa Chan, PharmD

Pharmacists and other clinicians are going to see digital therapeutics (DTx) and prescription digital therapeutics (PDTs) affect pharmacotherapy in the coming years, said Timothy Aungst, PharmD, lead author of a recent paper about PDTs published April 2, 2023, in JAPhA.

Loren Bonner

Fueled by celebrity endorsements, the increasing popularity of semaglutide injection (Wegovy—Novo Nordisk and Ozempic—Novo Nordisk) as a highly effective weight loss drug helped land it on FDA’s shortage list last year, where it remains today.

Sonya Collins

According to a new study published June 22, 2023, in the Lancet, the prevalence of diabetes will increase 60% worldwide by 2050. One key to the puzzle is how individuals and the health care community approach diabetes and how that relates to food and nutrition.

Mickie Cathers

Pharmacy Today proudly presents APhA’s Self-Care Product Survey. Conducted by BrandSpark/Newsweek International using a scientifically valid methodology, the survey determines those nonprescription products most often recommended by pharmacists in the United States to consumers.

Many opioid-related legal cases are currently being pursued against pharmacies, alleging that a patient’s brief period of opioid use years ago caused the patient to become addicted to opioids and that the dispensing pharmacy should be held legally liable for causing the patient’s overdose death years later.

David B. Brushwood, BSPharm, JD

Pharmacists all across the nation felt a boost when a law was passed in Maryland on May 3, 2023, allowing pharmacists in the state who are practicing within their scope of practice to be reimbursed by private and public health plans.

Loren Bonner

PrEP for HIV has made a significant impact in HIV prevention over the last decade. Since the combination of antiretrovirals tenofovir and emtricitabine (Truvada) earned FDA approval for the prevention of HIV in 2012, uptake among those for whom it is recommended has risen by an estimated 56% each year, according to data from Emory University’s Rollins School of Public Health. But major gaps remain between the number of people who could benefit from PrEP and the number who take it.

Sonya Collins

ACIP gathered to discuss several vaccine recommendations in June 2023. As a result of the meeting, recommendations surrounding the influenza virus vaccine, adult respiratory syncytial virus (RSV) vaccine, polio virus vaccine, and pneumococcal vaccine for children, among others, were all updated.

Lauren Howell, PharmD

Could point of care testing (POCT) services become as common as immunization services in pharmacies? Megan Smith, PharmD, lead author of a new study in JAPhA, thinks so.

Loren Bonner